Kane Biotech Inc (KNE.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Sales | 105 | 42 | 160 | 0 | 0 |
| Cost of Goods | 45 | 20 | 0 | 0 | 0 |
| Gross Profit | 60 | 22 | 160 | 0 | 0 |
| Operating Expenses | 1,794 | 1,545 | 1,611 | 1,464 | 1,235 |
| Operating Income | -1,734 | -1,523 | -1,451 | -1,464 | -1,235 |
| Interest Expense | 106 | 101 | 4 | 5 | 1 |
| Other Income | 130 | 10 | 7 | 9 | 1,236 |
| Pre-tax Income | -1,710 | -1,615 | -1,447 | -1,459 | N/A |
| Net Income Continuous | -1,710 | -1,615 | -1,447 | -1,459 | -1,221 |
| Net Income | $-1,710 | $-1,615 | $-1,447 | $-1,459 | $-1,221 |
| EPS Basic Total Ops | -0.09 | -0.09 | -0.09 | -0.09 | -0.09 |
| EPS Basic Continuous Ops | -0.09 | -0.09 | -0.09 | -0.09 | -0.09 |
| EPS Diluted Total Ops | -0.09 | -0.09 | -0.09 | -0.09 | -0.09 |
| EPS Diluted Continuous Ops | -0.09 | -0.09 | -0.09 | -0.09 | -0.09 |
| EBITDA(a) | $-1,561 | $-1,474 | $-1,349 | $-1,278 | $-1,166 |